These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22496218)

  • 1. Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection.
    Thobakgale CF; Fadda L; Lane K; Toth I; Pereyra F; Bazner S; Ndung'u T; Walker BD; Rosenberg ES; Alter G; Carrington M; Allen TM; Altfeld M
    J Virol; 2012 Jun; 86(12):6986-93. PubMed ID: 22496218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
    Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
    Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination.
    Jost S; Tomezsko PJ; Rands K; Toth I; Lichterfeld M; Gandhi RT; Altfeld M
    J Virol; 2014 Aug; 88(15):8349-54. PubMed ID: 24829350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.
    Dillon SM; Lee EJ; Bramante JM; Barker E; Wilson CC
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):259-67. PubMed ID: 24091697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
    Gooneratne SL; Center RJ; Kent SJ; Parsons MS
    Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.
    Tang CC; Isitman G; Bruneau J; Tremblay C; Bernard NF; Kent SJ; Parsons MS
    Clin Exp Immunol; 2015 Aug; 181(2):275-85. PubMed ID: 25644502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient IL-2 Produced by Activated CD56
    Xie Z; Zheng J; Wang Y; Li D; Maermaer T; Li Y; Tu J; Xu Q; Liang H; Cai W; Shen T
    Front Immunol; 2019; 10():1647. PubMed ID: 31379845
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.
    Naluyima P; Eller MA; Laeyendecker O; Quinn TC; Serwadda D; Sewankambo NK; Gray RH; Michael NL; Wabwire-Mangen F; Robb ML; Sandberg JK
    AIDS; 2014 Jun; 28(9):1273-8. PubMed ID: 24959961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing high-throughput methods to measure NK cell-mediated antibody dependent cellular cytotoxicity during HIV-infection.
    Konstantinus IN; Gamieldien H; Mkhize NN; Kriek JM; Passmore JA
    J Immunol Methods; 2016 Jul; 434():46-52. PubMed ID: 27094485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.
    Long BR; Ndhlovu LC; Oksenberg JR; Lanier LL; Hecht FM; Nixon DF; Barbour JD
    J Virol; 2008 May; 82(10):4785-92. PubMed ID: 18305035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals.
    Ahmad A; Menezes J
    AIDS; 1996 Feb; 10(2):143-9. PubMed ID: 8838701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid degranulation of NK cells following activation by HIV-specific antibodies.
    Chung AW; Rollman E; Center RJ; Kent SJ; Stratov I
    J Immunol; 2009 Jan; 182(2):1202-10. PubMed ID: 19124764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.
    Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Retière C; Geraghty DE; Bernard NF
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus.
    Rodriguez AR; Hodara V; Murthy K; Morrow L; Sanchez M; Bienvenu AE; Murthy KK
    Cell Immunol; 2014; 288(1-2):24-30. PubMed ID: 24565973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
    Nair MP; Schwartz SA
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals.
    Ahmad A; Morisset R; Thomas R; Menezes J
    J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):428-37. PubMed ID: 7908983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.
    Kant S; Zhang N; Barbé A; Routy JP; Tremblay C; Thomas R; Szabo J; Côté P; Trottier B; LeBlanc R; Rouleau D; Harris M; Dupuy FP; Bernard NF
    Front Immunol; 2020; 11():583820. PubMed ID: 33101312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions.
    Kottilil S; Shin K; Jackson JO; Reitano KN; O'Shea MA; Yang J; Hallahan CW; Lempicki R; Arthos J; Fauci AS
    J Immunol; 2006 Jan; 176(2):1107-14. PubMed ID: 16393999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.
    Loo CP; Long BR; Hecht FM; Nixon DF; Michaëlsson J
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):603-5. PubMed ID: 19500013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.